NCT02443766|Completed
Use of a Functional Neuroimaging Battery for the Evaluation of a Meditation Retreat
FETZER
Loading search results
FETZER
Sponsor study identifier
observational
14
1 country
1
Study Start
January 5, 2012
Actual (reported)Primary Completion
March 2, 2017
Actual (reported)Study Completion
March 2, 2017
Actual (reported)Over 2 decades scientists have been studying the effect on brain function from meditation practices. The purpose of this study is to measure the effect of a meditation retreat program on serotonin and dopamine transporter binding and changes in cerebral blood flow. The retreat program that will be followed is a week-long retreat called the Ignatian Retreat.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2, 2017
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 5, 2012
Actual (reported)February 6, 2015
Actual (reported)May 14, 2015
Actual (reported)March 2, 2017
Actual (reported)March 2, 2017
Actual (reported)Single Photon Emission Computed Tomography (SPECT) Imaging (DaTScan)
To detect changes in dopamine and serotonin before and after a meditation retreat program in serotonin transporter and dopamine transporter binding.
Within one month of the retreat
functional MRI
Within one month of the retreat
Speilberger State Trait Anxiety Inventory (STAI)
Within one month of the retreat
Profile of Moods Scale (POMS)
Within one month of the retreat
Beck Depression Inventory (Beck 1972)
Within one month of the retreat
Healthy subjects will attend the weeklong meditation retreat.
Weeklong retreat which includes meditation and prayer.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
At present, study participants are recruited from a variety of meditation programs and through the Center of Integrative Medicine. All subjects will be healthy adults.
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Andrew B. Newberg, MD
Thomas Jefferson University
14 participants (actual enrollment reported by the registry).
First Submitted
February 6, 2015
First Posted
May 14, 2015
Study Start
January 5, 2012
Actual (reported)Functional Neuroimaging of Alcoholism Vulnerability (PIT)
Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males
Contact the study team to confirm eligibility.
Primary Completion
March 2, 2017
Actual (reported)Study Completion
March 2, 2017
Actual (reported)Last Updated
July 25, 2022
Record last verified: 2022-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: